Search for: "United States v. Articles of Food and Drug"
Results 1 - 20
of 503
Sorted by Relevance
|
Sort by Date
8 Aug 2017, 1:27 pm
Earlier this year there was hope in the food and drug industries that the Supreme Court would revisit and possibly revise the Responsible Corporate Officer Doctrine, also known as the Park Doctrine, by granting certiorari to the Eighth Circuit’s decision in United States v. [read post]
29 Jul 2019, 5:21 am
Turtle Island Foods v. [read post]
16 Aug 2023, 11:08 am
According to the CDC, it is estimated that 1.4 million cases of salmonellosis occur each year in the United States. [read post]
2 Jul 2015, 11:33 am
Ct. 2653 (2011) and United States v. [read post]
SYNTHETIC DRUG BUSTS: FEDERAL ARRESTS FOR FAKE POT AND DESIGNER DRUGS THAT ARE LEGAL UNDER STATE LAW
31 May 2014, 1:34 pm
(B) The drug or other substance has a currently accepted medical use in treatment in the United States. [read post]
22 Jul 2019, 9:03 pm
FDA asked for the action in the United States of America vs. 24 Cases of Raisin Bran Cereal and J and L Grocery, LLC, and James T. and Lori A. [read post]
18 Sep 2017, 6:39 am
This Article demonstrates that—as suggested in the dissenting opinion in United States v. [read post]
22 Sep 2021, 11:48 am
United States Food and Drug Administration (“AAPS”), __ F.4th __, 2021 WL 4097325 (6th Cir. [read post]
13 Mar 2014, 12:22 pm
Under current law, as confirmed by the United States Supreme Court in the Pliva v. [read post]
29 Oct 2013, 12:49 pm
C & A Carbone, Inc. v. [read post]
15 Feb 2013, 4:00 am
The generic names, created to allow health workers to talk about the same drug without becoming confused by various manufacturers' proprietary names, are developed, in the United States at least, according to a scheme established by the United States Adopted Names Council [USAN], a scheme they describe as a "logical nomenclature classifications based on pharmacological and/or chemical relationships." [read post]
4 Mar 2009, 11:06 am
The New York Times Article may be read here: New York Times The Washington Post Article may be read here: Washington Post The Supreme Court opinion in Wyeth v. [read post]
26 Jun 2015, 12:11 pm
Attorney for the Southern District of New York; and Curtis Rosebraugh, Director of the Office of Drug Evaluation II, Office of New Drugs, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration. [read post]
24 Oct 2013, 5:52 am
Today's post was shared by WCBlog and comes from www.scotusblog.com Issue: Whether the Medical Device Amendments to the federal Food,Drug, and Cosmetic Act preempt a state-law claim alleging that a medical device manufacturer violated a duty under federal law to report adverse-event information to the Food and Drug Administration.DateProceedings and OrdersMar 28 2013Application (12A931) to extend the time to file a petition for a writ of certiorari from… [read post]
23 Mar 2012, 3:16 pm
Medical Device v. [read post]
15 Aug 2016, 8:13 am
It was in the highest appellate court in the land, the United States Supreme Court, that the final word was handed down. [read post]
16 Dec 2010, 1:59 am
The articles by Scallan et al. (1,2) in this issue represent the latest efforts to develop such estimates of the magnitude of foodborne illness in the United States. [read post]
28 Jan 2010, 4:51 am
In the United States, about 1.5 million preventable adverse drug events occur every year. [read post]
30 Jan 2009, 4:20 pm
See United States v. [read post]
31 Oct 2008, 2:38 pm
Levine is scheduled to be heard November 3, 2008 before the Supreme Court of the United States. [read post]
